Company filings profile · CIK 0001652935
ACTUATE THERAPEUTICS, INC. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for ACTUATE THERAPEUTICS, INC. (ACTU): 4 filings in the last 90 days vs 16 in the prior 90 (filing-velocity cooling ↓ · 0.25×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 7, 2026. Source-linked, daily-refreshed.
Material 8-K events — ACTUATE THERAPEUTICS, INC.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Jul 17, 2026 | Delisting / Listing-Rule Failure | ↗ |
| May 22, 2026 | Item 5.07 | ↗ |
| May 11, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 6, 2026 | Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits | ↗ |
| Jan 12, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Nov 28, 2025 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Nov 21, 2025 | Other Events | ↗ |
| Sep 10, 2025 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
Watch ACTUATE THERAPEUTICS, INC. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 6, 2026 | S-1 | REGISTRATION STATEMENT | ↗ |
| Aug 14, 2026 | 4 | ↗ | |
| Aug 14, 2026 | 10-Q | FORM 10-Q FOR JUN 2026 | ↗ |
| Jul 17, 2026 | 8-K | Delisting / Listing-Rule Failure | ↗ |
| Jun 8, 2026 | DRS | ↗ | |
| May 22, 2026 | 8-K | Item 5.07 | ↗ |
| May 22, 2026 | 4 | ↗ | |
| May 22, 2026 | 4 | ↗ | |
| May 22, 2026 | 4 | ↗ | |
| May 22, 2026 | 4 | ↗ | |
| May 22, 2026 | 4 | ↗ | |
| May 22, 2026 | 4 | ↗ | |
| May 22, 2026 | 4 | ↗ | |
| May 14, 2026 | S-8 | INITIAL REGISTRATION STATEMENT | ↗ |
| May 14, 2026 | 10-Q | FORM 10-Q FOR MAR 2026 | ↗ |
| May 11, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 6, 2026 | 3 | ↗ | |
| May 6, 2026 | DEFA14A | ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS | ↗ |
| May 6, 2026 | 8-K | Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits | ↗ |
| Apr 22, 2026 | SCHEDULE 13G/A | ↗ | |
| Apr 9, 2026 | ARS | 2025 ANNUAL REPORT | ↗ |
| Apr 6, 2026 | DEFA14A | DEFA14A | ↗ |
| Apr 6, 2026 | DEF 14A | DEF 14A | ↗ |
| Apr 1, 2026 | 4 | ↗ | |
| Apr 1, 2026 | 4 | ↗ | |
| Apr 1, 2026 | 4 | ↗ | |
| Mar 26, 2026 | 10-K | FORM 10-K FOR DEC 2025 | ↗ |
| Feb 13, 2026 | 4 | ↗ | |
| Jan 12, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jan 7, 2026 | 4 | ↗ | |
| Dec 17, 2025 | SCHEDULE 13G | ↗ | |
| Dec 11, 2025 | 144 | ↗ | |
| Nov 28, 2025 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Nov 28, 2025 | 424B5 | SUPPLEMENT TO PROSPECTUS DATED 9-8-25 | ↗ |
| Nov 21, 2025 | 8-K | Other Events | ↗ |
| Nov 13, 2025 | 10-Q | FORM 10-Q FOR SEP 2025 | ↗ |
| Sep 10, 2025 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 10, 2025 | 424B5 | PROSPECTUS | ↗ |
| Sep 9, 2025 | 424B5 | 424B5 | ↗ |
| Sep 8, 2025 | EFFECT | Item ; Item ; Item | ↗ |